Skip to main content
SpringerLink
Log in

Electroconvulsive Therapy

  • Chapter
  • First Online:
Psychiatric Neurotherapeutics

Part of the book series: Current Clinical Psychiatry ((CCPSY))

Abstract

Electroconvulsive therapy (ECT) was the first device-based treatment to become available for psychiatric disorders, and it consists of the application of an electric stimulus to the surface of the head, with the aim of inducing a seizure. To date, ECT is considered the gold standard device-based treatment for treatment-resistant depression (TRD), treatment-resistant bipolar disorder, and catatonia. The treatment is administered under general anesthesia two or three times a week for an acute series of 8–12 treatments. Common adverse effects include brief arrhythmias, headaches, muscle aches, and nausea. Cognitive side effects (e.g., memory disturbances) are also limited, although in some cases they may be long lasting. The mechanism of action of ECT is still unknown, and a number of hypotheses are being investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Washington, DC: APA; 2010.

    Google Scholar 

  2. UER Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361(9360):799–808.

    Article  Google Scholar 

  3. Kho KH, van Vreeswijk MF, Simpson S, Zwinderman AH. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT. 2003;19(3):139–47.

    Article  PubMed  Google Scholar 

  4. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–17.

    Article  PubMed  Google Scholar 

  5. Johnstone EC, Deakin JF, Lawler P, Frith CD, Stevens M, McPherson K, Crow TJ. The Northwick Park electroconvulsive therapy trial. Lancet. 1980;2(8208–8209):1317–20.

    Article  CAS  PubMed  Google Scholar 

  6. Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S. Electroconvulsive therapy: results in depressive illness from the Leicestershire trial. Br Med J (Clin Res Ed). 1984;288(6410):22–5.

    Article  CAS  Google Scholar 

  7. Gaynes BN, Lux L, Lloyd S, Hansen RA, Gartlehner G, Thieda P, Jonas D, Brode S, Swinson Evans T, Crotty K, Viswanathan M, Lohr KN. Nonpharmacologic interventions for treatment-resistant depression in adults. In: Agency for Healthcare Research and Quality, editor. Comparative effectiveness review. Rockville, MD: AHRQ Publication; 2011.

    Google Scholar 

  8. Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry. 2004;55(3):301–12.

    Article  PubMed  Google Scholar 

  9. Black DW, Winokur G, Nasrallah A. ECT in unipolar and bipolar disorders: a naturalistic evaluation of 460 patients. Convuls Ther. 1986;2(4):231–7.

    PubMed  Google Scholar 

  10. Hallam KT, Smith DI, Berk M. Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression. J Affect Disord. 2009;112(1–3):212–8.

    Article  CAS  PubMed  Google Scholar 

  11. Sienaert P, Vansteelandt K, Demyttenaere K, Peuskens J. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disord. 2009;11(4):418–24.

    Article  PubMed  Google Scholar 

  12. Medda P, Perugi G, Zanello S, Ciuffa M, Cassano GB. Response to ECT in bipolar I, bipolar II and unipolar depression. J Affect Disord. 2009;118(1–3):55–9.

    Article  CAS  PubMed  Google Scholar 

  13. Bailine S, Fink M, Knapp R, Petrides G, Husain MM, Rasmussen K, Sampson S, Mueller M, McClintock SM, Tobias KG, Kellner CH. Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr Scand. 2010;121(6):431–6.

    Article  CAS  PubMed  Google Scholar 

  14. Kellner CH, Knapp R, Husain MM, Rasmussen K, Sampson S, Cullum M, McClintock SM, Tobias KG, Martino C, Mueller M, Bailine SH, Fink M, Petrides G. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry. 2010;196:226–34.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kellner CH, Fink M, Knapp R, Petrides G, Husain M, Rummans T, Mueller M, Bernstein H, Rasmussen K, O’Connor K, Smith G, Rush AJ, Biggs M, McClintock S, Bailine S, Malur C. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry. 2005;162(5):977–82.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry. 1994;151(2):169–76.

    Article  CAS  PubMed  Google Scholar 

  17. Hatta K, Miyakawa K, Ota T, Usui C, Nakamura H, Arai H. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. J ECT. 2007;23(4):233–5.

    Article  CAS  PubMed  Google Scholar 

  18. Thirthalli J, Phutane VH, Muralidharan K, Kumar CN, Munishwar B, Baspure P, Gangadhar BN. Does catatonic schizophrenia improve faster with electroconvulsive therapy than other subtypes of schizophrenia? World J Biol Psychiatry. 2009;10(4 Pt 3):772–7.

    Article  PubMed  Google Scholar 

  19. van Waarde JA, Tuerlings JH, Verwey B, van der Mast RC. Electroconvulsive therapy for catatonia: treatment characteristics and outcomes in 27 patients. J ECT. 2010;26(4):248–52.

    Article  PubMed  Google Scholar 

  20. Rohland BM, Carroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord. 1993;29(4):255–61.

    Article  CAS  PubMed  Google Scholar 

  21. Consoli A, Benmiloud M, Wachtel L, Dhossche D, Cohen D, Bonnot O. Electroconvulsive therapy in adolescents with the catatonia syndrome: efficacy and ethics. J ECT. 2010;26(4):259–65.

    Article  PubMed  Google Scholar 

  22. Pompili M, Lester D, Dominici G, Longo L, Marconi G, Forte A, Serafini G, Amore M, Girardi P. Indications for electroconvulsive treatment in schizophrenia: a systematic review. Schizophr Res. 2013;146(1–3):1–9.

    Article  PubMed  Google Scholar 

  23. Fink M, Rush AJ, Knapp R, Rasmussen K, Mueller M, Rummans TA, O'Connor K, Husain M, Biggs M, Bailine S, Kellner CH. DSM melancholic features are unreliable predictors of ECT response: a CORE publication. J ECT. 2007;23(3):139–46.

    Article  PubMed  Google Scholar 

  24. Nordenskjold A, von Knorring L, Engstrom I. Predictors of the short-term responder rate of electroconvulsive therapy in depressive disorders—a population based study. BMC Psychiatry. 2012;12:115.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, Rummans TA, O'Connor KM, Rasmussen Jr KG, Bernstein HJ, Biggs M, Bailine SH, Kellner CH. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17(4):244–53.

    Article  CAS  PubMed  Google Scholar 

  26. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153(8):985–92.

    Article  CAS  PubMed  Google Scholar 

  27. Dombrovski AY, Mulsant BH, Haskett RF, Prudic J, Begley AE, Sackeim HA. Predictors of remission after electroconvulsive therapy in unipolar major depression. J Clin Psychiatry. 2005;66(8):1043–9.

    Article  PubMed  Google Scholar 

  28. Perugi G, Medda P, Zanello S, Toni C, Cassano GB. Episode length and mixed features as predictors of ECT nonresponse in patients with medication-resistant major depression. Brain Stimul. 2012;5(1):18–24.

    Article  CAS  PubMed  Google Scholar 

  29. Nuttall GA, Bowersox MR, Douglass SB, McDonald J, Rasmussen LJ, Decker PA, Oliver Jr WC, Rasmussen KG. Morbidity and mortality in the use of electroconvulsive therapy. J ECT. 2004;20(4):237–41.

    Article  PubMed  Google Scholar 

  30. Sackeim HA, Ross FR, Hopkins N, Calev L, Devanand DP. Subjective side effects acutely following ECT: associations with treatment modality and clinical response. Convuls Ther. 1987;3(2):100–10.

    PubMed  Google Scholar 

  31. Watts BV, Groft A, Bagian JP, Mills PD. An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. J ECT. 2011;27(2):105–8.

    Article  PubMed  Google Scholar 

  32. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328(12):839–46.

    Article  CAS  PubMed  Google Scholar 

  33. Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32(1):244–54.

    Article  PubMed  Google Scholar 

  34. Sackeim HA, Portnoy S, Neeley P, Steif BL, Decina P, Malitz S. Cognitive consequences of low-dosage electroconvulsive therapy. Ann N Y Acad Sci. 1986;462:326–40.

    Article  CAS  PubMed  Google Scholar 

  35. Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010;68(6):568–77.

    Article  PubMed  Google Scholar 

  36. Nobler MS, Sackeim HA. Neurobiological correlates of the cognitive side effects of electroconvulsive therapy. J ECT. 2008;24(1):40–5.

    Article  PubMed  Google Scholar 

  37. UE Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361(9360):799–808.

    Article  Google Scholar 

  38. Lisanby SH, Maddox JH, Prudic J, Devanand DP, Sackeim HA. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry. 2000;57(6):581–90.

    Article  CAS  PubMed  Google Scholar 

  39. Weiner RD, Rogers HJ, Davidson JR, Squire LR. Effects of stimulus parameters on cognitive side effects. Ann N Y Acad Sci. 1986;462:315–25.

    Article  CAS  PubMed  Google Scholar 

  40. Sobin C, Sackeim HA, Prudic J, Devanand DP, Moody BJ, McElhiney MC. Predictors of retrograde amnesia following ECT. Am J Psychiatry. 1995;152(7):995–1001.

    Article  CAS  PubMed  Google Scholar 

  41. Sackeim HA, Freeman J, McElhiney M, Coleman E, Prudic J, Devanand DP. Effects of major depression on estimates of intelligence. J Clin Exp Neuropsychol. 1992;14(2):268–88.

    Article  CAS  PubMed  Google Scholar 

  42. Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285(10):1299–307.

    Article  CAS  PubMed  Google Scholar 

  43. Odeberg H, Rodriguez-Silva B, Salander P, Martensson B. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study. J ECT. 2008;24(3):183–90.

    Article  PubMed  Google Scholar 

  44. Petrides G, Tobias KG, Kellner CH, Rudorfer MV. Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature. Neuropsychobiology. 2011;64(3):129–40.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, Mueller M, Bernstein HJ, O’Connor K, Smith G, Biggs M, Bailine SH, Malur C, Yim E, McClintock S, Sampson S, Fink M. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63(12):1337–44.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Vaidya NA, Mahableshwarkar AR, Shahid R. Continuation and maintenance ECT in treatment-resistant bipolar disorder. J ECT. 2003;19(1):10–6.

    Article  PubMed  Google Scholar 

  47. Wahlund B, von Rosen D. ECT of major depressed patients in relation to biological and clinical variables: a brief overview. Neuropsychopharmacology. 2003;28 Suppl 1:S21–6.

    Article  CAS  PubMed  Google Scholar 

  48. Kato N. Neurophysiological mechanisms of electroconvulsive therapy for depression. Neurosci Res. 2009;64(1):3–11.

    Article  PubMed  Google Scholar 

  49. Perrin JS, Merz S, Bennett DM, Currie J, Steele DJ, Reid IC, Schwarzbauer C. Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder. Proc Natl Acad Sci U S A. 2012;109(14):5464–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Sackeim HA, Decina P, Prohovnik I, Malitz S, Resor SR. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry. 1983;18(11):1301–10.

    CAS  PubMed  Google Scholar 

  51. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, Berman RM, Krystal JH. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry. 2003;160(3):577–9.

    Article  PubMed  Google Scholar 

  52. Mann JJ. Neurobiological correlates of the antidepressant action of electroconvulsive therapy. J ECT. 1998;14(3):172–80.

    Article  CAS  PubMed  Google Scholar 

  53. Markianos M, Hatzimanolis J, Lykouras L. Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course. Eur Arch Psychiatry Clin Neurosci. 2002;252(4):172–6.

    Article  PubMed  Google Scholar 

  54. Lisanby SH, Devanand DP, Prudic J, Pierson D, Nobler MS, Fitzsimons L, Sackeim HA. Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage. Biol Psychiatry. 1998;43(2):146–55.

    Article  CAS  PubMed  Google Scholar 

  55. Kamil R, Joffe RT. Neuroendocrine testing in electroconvulsive therapy. Psychiatr Clin N Am. 1991;14(4):961–70.

    CAS  Google Scholar 

  56. Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry. 1996;29(1):2–11.

    Article  CAS  PubMed  Google Scholar 

  57. Perera TD, Coplan JD, Lisanby SH, Lipira CM, Arif M, Carpio C, Spitzer G, Santarelli L, Scharf B, Hen R, Rosoklija G, Sackeim HA, Dwork AJ. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci. 2007;27(18):4894–901.

    Article  CAS  PubMed  Google Scholar 

  58. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000;47(12):1043–9.

    Article  CAS  PubMed  Google Scholar 

  59. Schmidt EZ, Reininghaus B, Enzinger C, Ebner C, Hofmann P, Kapfhammer HP. Changes in brain metabolism after ECT-positron emission tomography in the assessment of changes in glucose metabolism subsequent to electroconvulsive therapy—lessons, limitations and future applications. J Affect Disord. 2008;106(1–2):203–8.

    Article  CAS  PubMed  Google Scholar 

  60. Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA, Mann JJ. Decreased regional brain metabolism after ECT. Am J Psychiatry. 2001;158(2):305–8.

    Article  CAS  PubMed  Google Scholar 

  61. Rosa MA, Rosa MO, Marcolin MA, Fregni F. Cardiovascular effects of anesthesia in ECT: a randomized, double-blind comparison of etomidate, propofol, and thiopental. J ECT. 2007;23(1):6–8.

    Article  CAS  PubMed  Google Scholar 

  62. Krystal AD, Weiner RD, Dean MD, Lindahl VH, Tramontozzi 3rd LA, Falcone G, Coffey CE. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuropsychiatry Clin Neurosci. 2003;15(1):27–34.

    Article  CAS  PubMed  Google Scholar 

  63. Lerer B, Shapira B, Calev A, Tubi N, Drexler H, Kindler S, Lidsky D, Schwartz JE. Antidepressant and cognitive effects of twice-versus three-times-weekly ECT. Am J Psychiatry. 1995;152(4):564–70.

    Article  CAS  PubMed  Google Scholar 

  64. Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Praveen J, Reddy AK. Twice versus thrice weekly ECT in melancholia: a double-blind prospective comparison. J Affect Disord. 1993;27(4):273–8.

    Article  CAS  PubMed  Google Scholar 

  65. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57(5):425–34.

    Article  CAS  PubMed  Google Scholar 

  66. Fink M. Efficacy of ECT. Lancet. 1979;2(8155):1303–4.

    Article  CAS  PubMed  Google Scholar 

  67. Loo CK, Sainsbury K, Sheehan P, Lyndon B. A comparison of RUL ultrabrief pulse (0.3 ms) ECT and standard RUL ECT. Int J Neuropsychopharmacol. 2008;11(7):883–90.

    PubMed  Google Scholar 

  68. Verwijk E, Comijs HC, Kok RM, Spaans HP, Stek ML, Scherder EJ. Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: a review. J Affect Disord. 2012;140(3):233–43.

    Article  PubMed  Google Scholar 

  69. Dunne RA, McLoughlin DM. Systematic review and meta-analysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression. World J Biol Psychiatry. 2012;13(4):248–58.

    Article  PubMed  Google Scholar 

  70. Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrstrom J, Black C, Bech P. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand. 1996;94(4):241–51.

    Article  CAS  PubMed  Google Scholar 

  71. Sackeim HA, Dillingham EM, Prudic J, Cooper T, McCall WV, Rosenquist P, Isenberg K, Garcia K, Mulsant BH, Haskett RF. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry. 2009;66(7):729–37.

    Article  CAS  PubMed  Google Scholar 

  72. Dolenc TJ, Rasmussen KG. The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature. J ECT. 2005;21(3):165–70.

    Article  CAS  PubMed  Google Scholar 

  73. Baghai TC, Marcuse A, Brosch M, Schule C, Eser D, Nothdurfter C, Steng Y, Noack I, Pietschmann K, Moller HJ, Rupprecht R. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 2006;7(2):82–90.

    Article  PubMed  Google Scholar 

  74. Nothdurfter C, Eser D, Schule C, Zwanzger P, Marcuse A, Noack I, Moller HJ, Rupprecht R, Baghai TC. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 2006;7(3):162–70.

    Article  PubMed  Google Scholar 

  75. Ravanic DB, Pantovic MM, Milovanovic DR, Dukic-Dejanovic S, Janjic V, Ignjatovic DR, Jovic SD, Jurisic V, Jevtovic I. Long-term efficacy of electroconvulsive therapy combined with different antipsychotic drugs in previously resistant schizophrenia. Psychiatr Danub. 2009;21(2):179–86.

    CAS  PubMed  Google Scholar 

  76. Flamarique I, Castro-Fornieles J, Garrido JM, de la Serna E, Pons A, Bernardo M, Baeza I. Electroconvulsive therapy and clozapine in adolescents with schizophrenia spectrum disorders: is it a safe and effective combination? J Clin Psychopharmacol. 2012;32(6):756–66.

    Article  CAS  PubMed  Google Scholar 

  77. Loo CK, Schweitzer I, Pratt C. Recent advances in optimizing electroconvulsive therapy. Aust N Z J Psychiatry. 2006;40(8):632–8.

    Article  PubMed  Google Scholar 

  78. Lisanby SH, Moscrip T, Morales O, Luber B, Schroeder C, Sackeim HA. Neurophysiological characterization of magnetic seizure therapy (MST) in non-human primates. Suppl Clin Neurophysiol. 2003;56:81–99.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Depression Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, One Bowdoin Square, 6th Floor, Boston, MA, 02114, USA

    Cristina Cusin M.D.

Authors
  1. Cristina Cusin M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristina Cusin M.D. .

Editor information

Editors and Affiliations

  1. Medical School, Dept of Psychiatry, Massachusetts Gen Hosp, Harvard, Boston, Massachusetts, USA

    Joan A. Camprodon

  2. McLean Hospital, Belmont, Massachusetts, USA

    Scott L. Rauch

  3. Butler Hospital, Providence, Rhode Island, USA

    Benjamin D. Greenberg

  4. Harvard Medical School, Charleston, Massachusetts, USA

    Darin D. Dougherty

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cusin, C. (2016). Electroconvulsive Therapy. In: Camprodon, J., Rauch, S., Greenberg, B., Dougherty, D. (eds) Psychiatric Neurotherapeutics. Current Clinical Psychiatry. Humana Press, New York, NY. https://doi.org/10.1007/978-1-59745-495-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-495-7_4

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-934115-50-3

  • Online ISBN: 978-1-59745-495-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation